Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer
May 25, 2023•15 min
Episode description
Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD.
Related Content:
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast